Ultrasound-mediated destruction of paclitaxel and oxygen loaded lipid microbubbles for combination therapy in ovarian cancer xenografts

Cancer Letters

Volumn 361, Issue 1, 2015, Pages 147-154

  Liu, Li ^a,b   Chang, Shufang ^a   Sun, Jiangchuan ^a   Zhu, Shenyin ^c   Yin, Minyue ^a   Zhu, Yi ^a   Wang, Zhigang ^a   Xu, Ronald X ^a,d  

^a THE SECOND AFFILIATED HOSPITAL OF CHONGQING MEDICAL UNIVERSITY   (China)

^b State Key Lab of Ultrasound Eng in Med Co Founded by Chongqing and the Min of Sci and Technol   (China)

^c THE FIRST AFFILIATED HOSPITAL OF CHONGQING MEDICAL UNIVERSITY   (China)

^d Ohio State University   (United States)

Author keywords

Drug delivery; Microbubbles; Ovarian cancer; Oxygen; Ultrasound

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1ALPHA; MULTIDRUG RESISTANCE PROTEIN; OXYGEN; PACLITAXEL; VASCULOTROPIN; ANTINEOPLASTIC AGENT; HIF1A PROTEIN, MOUSE; LIPID; VASCULAR ENDOTHELIAL GROWTH FACTOR A, MOUSE; VASCULOTROPIN A;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER INHIBITION; CANCER TISSUE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG RELEASE; ECHOGRAPHY; FEMALE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; MICROBUBBLE; NONHUMAN; OVARIAN CANCER CELL LINE; OVARY CANCER; OXYGEN AND PACLITAXEL LOADED MICROBUBBLE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SINGLE DRUG DOSE; TISSUE DISTRIBUTION; TUMOR VOLUME; TUMOR XENOGRAFT; WESTERN BLOTTING; ANIMAL; BAGG ALBINO MOUSE; CELL PROLIFERATION; CHEMISTRY; DRUG EFFECTS; DRUG SCREENING; METABOLISM; MOUSE; MULTIMODALITY CANCER THERAPY; NUDE MOUSE; OVARIAN NEOPLASMS; PATHOLOGY; RADIATION RESPONSE; TUMOR CELL CULTURE; ULTRASOUND;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; BLOTTING, WESTERN; CELL PROLIFERATION; COMBINED MODALITY THERAPY; DRUG DELIVERY SYSTEMS; FEMALE; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; LIPIDS; MICE; MICE, INBRED BALB C; MICE, NUDE; MICROBUBBLES; OVARIAN NEOPLASMS; OXYGEN; P-GLYCOPROTEIN; PACLITAXEL; TUMOR CELLS, CULTURED; ULTRASONICS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84925248323     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2015.02.052     Document Type: Article

References (37)

1. Siegel R., Naishadham D., Jemal A. Cancer statistics, 2013. CA Cancer J. Clin 2013, 63(1):11-30.
2. Terplan M., Smith E.J., Temkin S.M. Race in ovarian cancer treatment and survival: a systematic review with meta-analysis. Cancer Causes Control 2009, 20(7):1139-1150.
3. Jain R.K. Delivery of molecular and cellular medicine to solid tumors. J. Control. Release 1998, 53(1-3):49-67.
4. Fukumura D., Jain R.K. Tumor microvasculature and microenvironment: targets for anti-angiogenesis and normalization. Microvasc. Res 2007, 74(2-3):72-84.
5. Boucher Y., Leunig M., Jain R.K. Tumor angiogenesis and interstitial hypertension. Cancer Res 1996, 56(18):4264-4266.
6. McDonald D.M., Baluk P. Significance of blood vessel leakiness in cancer. Cancer Res 2002, 62(18):5381-5385.
7. Brown J.M. Tumor hypoxia, drug resistance, and metastases. J. Natl Cancer Inst 1990, 82(5):338-339.
8. Mayer A., Vaupel P. Hypoxia, lactate accumulation, and acidosis: siblings or accomplices driving tumor progression and resistance to therapy?. Adv. Exp. Med. Biol 2013, 789:203-209.
9. Milane L., Duan Z., Amiji M. Role of hypoxia and glycolysis in the development of multi-drug resistance in human tumor cells and the establishment of an orthotopic multi-drug resistant tumor model in nude mice using hypoxic pre-conditioning. Cancer Cell Int 2011, 11:3.
10. Moen I., Stuhr L.E. Hyperbaric oxygen therapy and cancer - a review. Target. Oncol 2012, 7(4):233-242.
11. Song X., Liu X., Chi W., Liu Y., Wei L., Wang X., et al. Hypoxia-induced resistance to cisplatin and doxorubicin in non-small cell lung cancer is inhibited by silencing of HIF-1alpha gene. Cancer Chemother. Pharmacol 2006, 58(6):776-784.
12. Al-Waili N.S., Butler G.J., Beale J., Hamilton R.W., Lee B.Y., Lucas P. Hyperbaric oxygen and malignancies: a potential role in radiotherapy, chemotherapy, tumor surgery and phototherapy. Med. Sci. Monit 2005, 11(9):RA279-RA289.
13. Milane L., Ganesh S., Shah S., Duan Z.F., Amiji M. Multi-modal strategies for overcoming tumor drug resistance: hypoxia, the Warburg effect, stem cells, and multifunctional nanotechnology. J. Control. Release 2011, 155(2):237-247.
14. Moen I., Tronstad K.J., Kolmannskog O., Salvesen G.S., Reed R.K., Stuhr L.E. Hyperoxia increases the uptake of 5-fluorouracil in mammary tumors independently of changes in interstitial fluid pressure and tumor stroma. BMC Cancer 2009, 9:446.
15. Pu C., Chang S., Sun J., Zhu S., Liu H., Zhu Y., et al. Ultrasound-mediated destruction of LHRHa-targeted and paclitaxel-loaded lipid microbubbles for the treatment of intraperitoneal ovarian cancer xenografts. Mol. Pharm 2014, 11(1):49-58.
16. Kotopoulis S., Dimcevski G., Gilja O.H., Hoem D., Postema M. Treatment of human pancreatic cancer using combined ultrasound, microbubbles, and gemcitabine: a clinical case study. Med. Phys 2013, 40(7). 072902.
17. Huang P., You X., Pan M., Li S., Zhang Y., Zhao Y., et al. A novel therapeutic strategy using ultrasound mediated microbubbles destruction to treat colon cancer in a mouse model. Cancer Lett 2013, 335(1):183-190.
18. Xu R.X., Huang J., Xu J.S., Sun D., Hinkle G.H., Martin E.W., et al. Fabrication of indocyanine green encapsulated biodegradable microbubbles for structural and functional imaging of cancer. J. Biomed. Opt 2009, 14(3). 034020.
19. Li P., Zheng Y., Ran H., Tan J., Lin Y., Zhang Q., et al. Ultrasound triggered drug release from 10-hydroxycamptothecin-loaded phospholipid microbubbles for targeted tumor therapy in mice. J. Control. Release 2012, 162(2):349-354.
20. Liu H., Chang S., Sun J., Zhu S., Pu C., Zhu Y., et al. Ultrasound-mediated destruction of LHRHa-targeted and paclitaxel-loaded lipid microbubbles induces proliferation inhibition and apoptosis in ovarian cancer cells. Mol. Pharm 2014, 11(1):40-48.
21. van Wamel A., Kooiman K., Harteveld M., Emmer M., ten Cate F.J., Versluis M., et al. Vibrating microbubbles poking individual cells: drug transfer into cells via sonoporation. J. Control. Release 2006, 112(2):149-155.
22. Ferrara K., Pollard R., Borden M. Ultrasound microbubble contrast agents: fundamentals and application to gene and drug delivery. Annu. Rev. Biomed. Eng 2007, 9:415-447.
23. Spahn D.R., Kocian R. Artificial O2 carriers: status in 2005. Curr. Pharm. Des 2005, 11(31):4099-4114.
24. Lowe K.C. Perfluorinated blood substitutes and artificial oxygen carriers. Blood Rev 1999, 13(3):171-184.
25. Cavalli R., Bisazza A., Rolfo A., Balbis S., Madonnaripa D., Caniggia I., et al. Ultrasound-mediated oxygen delivery from chitosan nanobubbles. Int. J. Pharm 2009, 378(1-2):215-217.
26. Kheir J.N., Scharp L.A., Borden M.A., Swanson E.J., Loxley A., Reese J.H., et al. Oxygen gas-filled microparticles provide intravenous oxygen delivery. Sci. Transl. Med 2012, 4(140). 140ra188.
27. Sun J., Yin M., Chang S., Zhu S., Liu L., Zhu Y., et al. Ultrasound-mediated destruction of oxygen and paclitaxel loaded lipid microbubbles for combination therapy in hypoxic ovarian cancer cells. PLoS ONE 2015, submitted.
28. Wang Y., Wu K.C., Zhao B.X., Zhao X., Wang X., Chen S., et al. A novel paclitaxel microemulsion containing a reduced amount of Cremophor EL: pharmacokinetics, biodistribution, and in vivo antitumor efficacy and safety. J. Biomed. Biotechnol 2011, 2011. 854872.
29. Yasuda H. Solid tumor physiology and hypoxia-induced chemo/radio-resistance: novel strategy for cancer therapy: nitric oxide donor as a therapeutic enhancer. Nitric Oxide 2008, 19(2):205-216.
30. Wu J., Nyborg W.L. Ultrasound, cavitation bubbles and their interaction with cells. Adv. Drug Deliv. Rev 2008, 60(10):1103-1116.
31. Skyba D.M., Price R.J., Linka A.Z., Skalak T.C., Kaul S. Direct in vivo visualization of intravascular destruction of microbubbles by ultrasound and its local effects on tissue. Circulation 1998, 98(4):290-293.
32. Price R.J., Skyba D.M., Kaul S., Skalak T.C. Delivery of colloidal particles and red blood cells to tissue through microvessel ruptures created by targeted microbubble destruction with ultrasound. Circulation 1998, 98(13):1264-1267.
33. Xu R.X., Xu J.S., Zuo T., Shen R., Huang T.H., Tweedle M.F. Drug-loaded biodegradable microspheres for image-guided combinatory epigenetic therapy in cells. J. Biomed. Opt 2011, 16(2):020507.
34. Hwang J.H., Brayman A.A., Reidy M.A., Matula T.J., Kimmey M.B., Crum L.A. Vascular effects induced by combined 1-MHz ultrasound and microbubble contrast agent treatments in vivo. Ultrasound Med. Biol 2005, 31(4):553-564.
35. Geers B., Lentacker I., Sanders N.N., Demeester J., Meairs S., De Smedt S.C. Self-assembled liposome-loaded microbubbles: the missing link for safe and efficient ultrasound triggered drug-delivery. J. Control. Release 2011, 152(2):249-256.
36. Ikeda R., Vermeulen L.C., Jiang Z., Lau E., Kolesar J.M. Gemcitabine and paclitaxel suppress the production of vascular endothelial growth factor induced by deferoxamine in human non-small cell lung cancer A549 cells. Exp. Ther. Med 2010, 1(5):853-857.
37. Teng M., Jiang X.P., Zhang Q., Zhang J.P., Zhang D.X., Liang G.P., et al. Microtubular stability affects pVHL-mediated regulation of HIF-1alpha via the p38/MAPK pathway in hypoxic cardiomyocytes. PLoS ONE 2012, 7(4). e35017.